ArticleCase reports in oncology
Incidental Gallbladder Carcinoma Discovered during Living Liver Donor Evaluation.
Article in Case reports in oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Gallbladder cancer (GBC) is the most common and aggressive malignancy of the biliary tract, often diagnosed at an advanced stage with a poor prognosis due to its typically insidious onset and nonspecific symptoms. Early-stage GBC is usually asymptomatic and most frequently discovered incidentally following cholecystectomy for presumed benign disease. This case report details the rare incidental discovery of GBC in a potential living liver donor, an individual significantly younger than the typical demographic for this cancer, highlighting the value of comprehensive donor screening protocols. Case Presentation: A 45-year-old asymptomatic Arab female with no significant medical history was evaluated as a potential living liver donor for her brother. Routine preoperative imaging revealed marked gallbladder wall thickening, a solitary gallstone larger than 3 cm, and a suspicious mass extending into the liver. A subsequent PET/CT scan confirmed an FDG-avid lesion localized to the gallbladder and adjacent liver, with no evidence of distant metastasis. The patient underwent an open en bloc resection of the gallbladder with hepatic segments IVb and V. Histopathological examination confirmed a moderately differentiated adenocarcinoma (pT2bN1M0, stage IIIB). The patient recovered well postoperatively and completed six cycles of adjuvant chemotherapy. At a 3-year follow-up, she remains asymptomatic with no evidence of disease recurrence. Conclusion: This case represents a unique and valuable contribution to the medical literature, documenting a rare incidental finding of gallbladder carcinoma in an asymptomatic living liver donor candidate. The rigorous screening protocols standard for living organ donation proved to be lifesaving by uncovering an occult malignancy at a treatable stage. This report underscores the importance of maintaining a high index of suspicion for any gallbladder abnormalities detected during donor evaluation and serves as a critical reference for transplant, surgical, and oncology teams.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.